Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Bioorg Med Chem
2010 Apr 01;187:2566-74. doi: 10.1016/j.bmc.2010.02.034.
Show Gene links
Show Anatomy links
Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.
Watts KR
,
Ratnam J
,
Ang KH
,
Tenney K
,
Compton JE
,
McKerrow J
,
Crews P
.
???displayArticle.abstract???
Human African trypanosomiasis (HAT, commonly known as African sleeping sickness) is categorized as a neglected disease, as it afflicts >50,000 people annually in sub-saharan Africa, and there are few formal programs in the world focused on drug discovery approaches for this disease. In this study, we examined the crude extracts of two fungal strains (Aspergillus fumigatus and Nectria inventa) isolated from deep water sediment which provided >99% growth inhibition at 1microg/mL of Trypanosoma brucei, the causative parasite of HAT. A collection of fifteen natural products was supplemented with six semi-synthetic derivatives and one commercially available compound. Twelve of the compounds, each containing a diketopiperazine core, showed excellent activity against T. brucei (IC(50)=0.002-40microM), with selectivity over mammalian cells as great as 20-fold. The trypanocidal diketopiperazines were also tested against two cysteine protease targets Rhodesain and TbCatB, where five compounds showed inhibition activity at concentrations less than 20microM. A preliminary activity pattern is described and analyzed.
Abdulla,
RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model.
2008, Pubmed
Abdulla,
RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model.
2008,
Pubmed
Bakunova,
Structure-activity study of pentamidine analogues as antiprotozoal agents.
2009,
Pubmed
Barrett,
Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.
2007,
Pubmed
Boot,
Pinpointing pseurotins from a marine-derived Aspergillus as tools for chemical genetics using a synthetic lethality yeast screen.
2007,
Pubmed
Caffrey,
Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Trypanosoma brucei rhodesiense.
2001,
Pubmed
Cordeiro,
Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites.
2009,
Pubmed
de Koning,
Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes.
2008,
Pubmed
Eakin,
Production of crystallizable cruzain, the major cysteine protease from Trypanosoma cruzi.
1993,
Pubmed
Fayos,
Letter: Structure of verruculogen, a tremor producing peroxide from Penicillium verruculosum.
1974,
Pubmed
Fujimoto,
Immunomodulatory constituents from an Ascomycete, Chaetomium seminudum.
2004,
Pubmed
Gautschi,
Expanding the strategies in natural product studies of marine-derived fungi: a chemical investigation of penicillium obtained from deep water sediment.
2004,
Pubmed
Greenbaum,
Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
2004,
Pubmed
Hauser,
[Isolation and configuration of Chaetocin].
1970,
Pubmed
Hoet,
Natural products active against African trypanosomes: a step towards new drugs.
2004,
Pubmed
Jennings,
The use of the 2 substituted 5-nitroimidazole, Fexinidazole (Hoe 239) in the treatment of chronic T. brucei infections in mice.
1983,
Pubmed
Johnson,
The aignopsanes, a new class of sesquiterpenes from selected chemotypes of the sponge Cacospongia mycofijiensis.
2009,
Pubmed
Kanoh,
(-)-Phenylahistin arrests cells in mitosis by inhibiting tubulin polymerization.
1999,
Pubmed
Kennedy,
The continuing problem of human African trypanosomiasis (sleeping sickness).
2008,
Pubmed
Latgé,
Aspergillus fumigatus and aspergillosis.
1999,
Pubmed
Li,
Prenylated indole derivatives from fungi: structure diversity, biological activities, biosynthesis and chemoenzymatic synthesis.
2010,
Pubmed
Mackey,
Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei.
2006,
Pubmed
Mallari,
Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB.
2008,
Pubmed
Mallari,
Development of potent purine-derived nitrile inhibitors of the trypanosomal protease TbcatB.
2008,
Pubmed
Mallari,
Structure-guided development of selective TbcatB inhibitors.
2009,
Pubmed
Minagawa,
An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei.
1997,
Pubmed
Minato,
Studies on the metabolites of Verticillium sp. structures of Verticillins A, B, and C.
1973,
Pubmed
O'Brien,
A parasite cysteine protease is key to host protein degradation and iron acquisition.
2008,
Pubmed
Ojo,
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.
2008,
Pubmed
Okamoto,
Studies of platelet activating factor (PAF) antagonists from microbial products. I. Bisdethiobis(methylthio)gliotoxin and its derivatives.
1986,
Pubmed
Osterhage,
Ascosalipyrrolidinone A, an antimicrobial alkaloid, from the obligate marine fungus Ascochyta salicorniae.
2000,
Pubmed
Priotto,
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
2009,
Pubmed
Rubio,
The marine sponge Diacarnus bismarckensis as a source of peroxiterpene inhibitors of Trypanosoma brucei, the causative agent of sleeping sickness.
2009,
Pubmed
SANNER,
Studies on the active--SH group of papain and on the mechanism of papain activation by thiols.
1963,
Pubmed
Schroeder,
Tremorgenic mycotoxins from Aspergillus caespitosus.
1975,
Pubmed
Smith,
First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sickness.
2009,
Pubmed
Van der Pyl,
Inhibition of farnesyl-protein transferase by gliotoxin and acetylgliotoxin.
1992,
Pubmed
Zhang,
Cytotoxic alkaloids and antibiotic nordammarane triterpenoids from the marine-derived fungus Aspergillus sydowi.
2008,
Pubmed
